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Abstract 
Introduction: IgG4-related disease was first reported in 2001 and was officially named in 2010. It is now considered 
as a systemic disease that might affect any organ system. The characteristic pathological changes of IgG4-related dis-
ease are extensive infiltration of IgG4-positive plasma cells. IgG4-related disease is a kind of benign lesions, but there 
has not been well-defined standard treatment so far. Patients usually respond well to corticosteroids. The prognosis of 
IgG4-related disease is perhaps good as long as early detection and treatment.
Case description: We report one case of IgG4-related disease with a 16-years anamnesis with multi-pseudotumor 
masses. He was diagnosed with chronic kidney disease with wide interstitial renal fibrosis. And he received gluco-
corticoids therapy. After 2 month therapy, the serum creatinine, erythrocyte sedimentation rate, and serum IgG4 
decreased significantly. The discussion includes presentation, clinical course, diagnosis, and prognosis of IgG4-related 
disease. The case and discussion highlight the importance of diagnosis and the good prognosis of IgG4-related 
diseases.
Discussion and evaluation: Our case highlights the importance of diagnosis and the good prognosis of IgG4-
related diseases. IgG4-related disease is a systemic fibro-inflammatory immune-mediated disorder and now rec-
ognized in almost every major organs. Characteristics of the disease is multiple lymph nodes and the response to 
glucocorticoids therapy is well. In such case, he had a history of 16 years with multi-pseudotumor masses and misdi-
agnosed for 16 years, if the doctors were not awareness of higher serum immunoglobulin G4 (IgG4) than normal, the 
correct diagnosis may be missed or delayed. Consequently, appropriate treatment for IgG4-related disease would also 
be delayed or not provided and likely result in increased morbidity and mortality.
Conclusions: IgG4-related disease is a systemic fibro-inflammatory immune-mediated disorder and progresses 
slowly. In the present patient the course of IgG4-related disease appears to be benign. The prognosis of IgG4-related 
disease depend on early diagnosis and treatment.
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Introduction
IgG4-related disease is now considered as a systemic dis-
ease that might affect any organ system, including kid-
neys, lymph nodes, and thyroid gland, with progressively 
growing fibro-inflammatory lesions causing a mass effect. 
Diagnostic criteria were established as: IgG4 plasma level 
of >135 mg/dl and an IgG4/IgG plasma cell ratio of >40 % 
with >10 and IgG4-positive plasma cells per HPF. Mac-
roscopically, these diseases cause diffuse organ swelling 
and formation of pseudotumor masses. Patients usually 
respond well to corticosteroids, but highly active diseases 
may require other immunosuppressive therapies. IgG4-
related disease was first reported in 2001, which came 
from autoimmune pancreatitis (AIP) and was officially 
named in 2010. The prognosis of the disease has not 
been clearly defined. We hereby reported a 54-year-old 
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male with IgG4-related disease, a history of 16 years with 
multi-pseudotumor masses, he was diagnosed as chronic 
kidney disease with Scr 545 µmol/L and interstitial renal 
fibrosis widely. And the response to glucocorticoids 
therapy was well. After 1 month therapy, the Serum cre-
atinine (Scr), erythrocyte sedimentation rate (ESR), and 
IgG4 decreased significantly.
Case report
IgG4-related disease was diagnosed in a 54-year-old male 
with lumps in both orbital cavity for more than 16 years 
and lymphadenopathy in mediastinum for 11 years prior 
to hospital admission. In March 2000, a 54-year-old man 
was present in a local hospital because of exophthal-
mos for one year. The physical examination showed that 
there was hard lumps out of the top of left orbital cavity 
(0.5 × 0.5 cm) and larger tender bilateral submandibular 
lymph nodes. A computed tomography (CT) scanning 
and ophthalmic ultrasound indicated that occupying 
lesion  located in left orbital cavity. Scr was 76  µmol/L. 
Pathology of lumps in the orbit was “inflammatory pseu-
dotumor (benign lymphoma)”, and he was given pred-
nisone, 30 mg qd. After 2 weeks, bilateral submandibular 
lymph nodes shrunk significantly (0.3 × 0.3 cm).
During April 2000 to May 2004, the patient did not go 
to see any doctor for the above disease. At June 2004, he 
received CT scanning examination, and there still was 
swelling lymph nodes in mediastinum and abdomen. He 
was given prednisone (unknown exact dose and duration, 
but he refused following-up in local hospital. At Janu-
ary 2015, he went to local hospital because of constipa-
tion and abdominal pain. Examination results showed 
that Scr elevated (396 µmol/L) and proteinuria was posi-
tive (+), then he accepted some relative treatments. But 
at early of May 2015, Scr increased to 488 µmol/L, so he 
was admitted to our hospital. His prior medical history 
also included mild lower extremity numbness for more 
than 5 years.
Results of a physical examination revealed that there 
were enlarged lymph nodes behind the left ear, right groin 
and left orbital cavity, each was about 1.0 × 1.0 cm. There 
was no malar rash, oral ulcers, diffuse alopecia or edema 
in bilateral eyelids and lower limbs. Pertinent laboratory 
findings included an ESR of 101 mm/h. White blood cell 
count, platelet count, and hemoglobin were all normal. 
Parathyroid hormone (PTH) was 351  pg/ml. Ca2+ and 
P3+ were normal. Anti-glomerular basement membrane 
antibody and anti-neutrophil antibody was negative. The 
ratio of light chain κ/λ in urine and blood were normal. 
Urinary albumin-creatinine ratio (ACR) was 0.25  g/gCr. 
The serum immunoglobulin G (IgG) was 57,500  mg/L 
(reference range 20,000–40,000  mg/L) accounting for 
50.3 % of total immunoglobulin, significantly higher than 
normal (normal 9–16 %). Serum immunofixation electro-
phoresis was negative. Level of C3 and C4 were normal.
After admission, laboratory tests were positive for 
serum immunoglobulin G4 (IgG4), 38,500 mg/L (normal 
30–2010  mg/L), accounting for 66.9  % of total IgG. CT 
scanning showed there were enlarged lymph nodes in the 
left side of face, in bilateral orbital cavity, and bilateral 
temporal fossa. Scanning of CT indicated that there were 
thyroid nodules and enlarged lymph nodes in mediasti-
num, abdominal cavity, and retroperitoneum. The mor-
phology of peripheral blood cell was normal.
The patient accepted renal biopsy but refused lymph 
node biopsy. We obtained two renal biopsy specimens, 
and each specimen with length of about 1 cm contained 
100 % cortex with 13 glomeruli. On light microscopy of 
hematoxylin-eosin staining, there was total 13 glomer-
uli, including 6 glomeruli completely fibrosis and 3 glo-
meruli peribulbar fibrosis. The mesangial cell and matrix 
showed no proliferation, there was no thickening of glo-
merular capillary. In Masson staining, no immune com-
plexes deposited in capillary wall. In PASM staining, 60 % 
of tubules were atrophic, others showed dilatation with 
flat epithelial cells, renal interstitial showed diffuse fibro-
sis with a large number of plasma cell diffuse infiltration 
and IgG4 staining was positive (average 47 IgG4-positive 
plasma cells per high power field) (Figs. 1, 2 3).
The result of electron microscopy showed: there was 
no significant proliferation and expansion in mesangial 
cells and matrix. The capillary wall basement membrane 
showed diffuse thickening and shrinkage, without sig-
nificant electron dense deposit. Foot process of podo-
cyte appeared diffuse effacement. Tubular epithelial cell 
and organelle swollen. Tubular basement membrane was 
Fig. 1 A large number of plasma cell diffuse infiltration and IgG4 
staining was positive and tubules atrophy, renal interstitial diffuse 
fibrosis. IgG4-immunostaining and Masson staining (×400)
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almost normal. The interstitium showed focal edema, 
fibrosis with inflammatory cell infiltration.
According to clinical manifestations, laboratory find-
ings, and imaging results, the case was diagnosed as 
IgG4-related disease. He was managed with standard 
prednisolone with relative drugs. Ten days later, Scr and 
ESR decreased. Enlarged lymph nodes behind of left ear, 
right groin and left orbital cavity, became significantly 
smaller 10  days after starting steroid therapy, each was 
about 0.5  ×  0.5  cm. Lower extremity numbness also 
mitigated.
One month later, he returned for re-examination. 
Enlarged lymph nodes in the behind of left ear, right 
groin and left orbital cavity disappeared. Lower extremity 
numbness also disappeared. ESR decreased to 15 mm/h, 
Scr decreased to 311  µmol/L, urinary ACR was 0.2  g/
gCr and level of IgG4 decreased to 8500 mg/L. Enlarged 
lymph nodes became smaller than before in CT. Two 
months later, level of IgG4 decreased to 2060 mg/L.
Discussions
IgG4-related disease is a disease associated with serum 
increased IgG4, which is involved in chronic and autoim-
mune disease in multiple organs and/or tissues (Grados 
et al. 2015), including many kinds of diseases (Furukawa 
et al. 2015; Yakirevich et al. 2015; Nishikawa et al. 2014; 
Kragstrup et al. 2013; Ahn et al. 2014; Huggett et al. 2014; 
Pusztaszeri et  al. 2012; Hori et  al. 2010), for example, 
inflammatory pseudotumor (Choi et al. 2015), Mikulicz`s 
disease (Takano et  al. 2014), and autoimmune pancrea-
titis (AIP) (Yakirevich et  al. 2015). AIP often expresses 
acute or chronic pancreatitis and imaging scanning 
shows characteristic sausage-type swelling of the pan-
creas (Hara et  al. 2014; Brito-Zerón et  al. 2014; Eu Jin 
et  al. 2010). The relationship of AIP and IgG4-positive 
plasma cells was introduced and presented for the first 
time in 2001 with a typical biopsy specimen revealed a 
large number of IgG4-positive plasma cell infiltration. 
IgG4 systemic disease was also called IgG4-related dis-
ease or lgG4-related multi-organ lymphoproliferative 
syndrome (Pieringer et al. 2014). In the year 2010, IgG4-
related disease were announced to birth on Autoimmun 
Rev magazine (Yoshida et al. 1995; Takahashi et al. 2010). 
In the present report, the patient was diagnosed inflam-
matory pseudotumor at first time in the year 2000, and 
after 15  years, he was finally diagnosed as IgG4-related 
disease.
The characteristic pathological changes of IgG4-related 
disease are extensive infiltration of IgG4-positive plasma 
cells in tissues and multiple organs, which lead to fibrosis 
(Martinez et  al. 2014). CD4+ and CD8+ T cells may be 
involved in occurrence of IgG4-related disease. In addi-
tion, long-term asbestos exposure may be a predisposing 
factor (Toyoshima et al. 2010). There are some common 
characteristics in IgG4-related disease, including swell-
ing and sclerosis in one or more organs or tissues, similar 
to tumor; IgG4/IgG plasma cell ratio >40 % with >10 and 
IgG4-positive plasma cells per HPF; IgG4 plasma level 
>1350 mg/L; good response to glucocorticoid therapy.
In present study, the patient had lumps in both orbital 
cavity for 16  years, swelling lymph nodes in mediasti-
num and abdomen at least for 11  years and the pathol-
ogy of lumps in the orbit was diagnosed as “inflammatory 
pseudotumor (benign lymphoma)” in the year 2000. 
Because of the limited medical knowledge of IG4-related 
systemic disease in the year 2000, IgG4 staining did not 
Fig. 2 A large number of plasma cell diffuse infiltration and IgG4 
staining was positive and tubules atrophy, renal interstitial diffuse 
fibrosis. PASM (Periodic acid-silver metheramine) staining (×400)
Fig. 3 A large number of plasma cell diffuse infiltration and IgG4 
staining was positive and tubules atrophy, renal interstitial diffuse 
fibrosis. HE (Hematoxylin-eosin) staining (×200)
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completed at that time. Unfortunately the specimens at 
diagnosis were lost and we could not perform IgG4 stain-
ing. CT scanning at different timepoints showed enlarged 
lymph nodes in many organs. Laboratory tests was posi-
tive, 38,500 mg/L, for IgG4, >1350 mg/L, accounting for 
66.9 % of total IgG (>40 %). In renal biopsy, 60 % tubules 
was atrophy, other tubules showed dilatation with flat 
epithelial cells, renal interstitial showed diffuse fibrosis 
with diffuse infiltration of a large number of plasma cell 
and IgG4 staining was positive (Figs. 1, 2 3) (Cortazar and 
Stone 2015).
 Previous reports showed that IgG4-related disease is 
a kind of benign lesions, but there has not been well-
defined standard treatment so far. It was generally 
sensitive to glucocorticoids (Wallace and Stone 2015; 
Hasegawa et al. 2015). After glucocorticoids treatment, 
organs or tissues swelling subsided significantly, serum 
IgG4 decreased and clinical manifestations were amelio-
rated significantly, but if discontinuing glucocorticoid, it 
may relapses. In the present study, the patient received 
prednisone, 30  mg qd, for 2  weeks in the year 2000. 
After 14  days, lymph nodes in bilateral submandibular 
became significantly smaller. And in the year 2015, he 
received again prednisolone. At 10-day-, 1-month- and 
2-month following-up, Scr, IgG4, and ESR significantly 
decreased. Enlarged lymph nodes became significantly 
smaller.
It has been only 15  years since the first IgG4-related 
system diseases was reported Takahashi et  al. (2010), 
and the long-term prognosis of IgG4-related systemic 
was still unclear. In the present study it was more than 
16 years since the lumps in both orbital cavity first found.
During this period, he did not receive systemic therapy. 
Because of increased Scr, he went to see a doctor and 
IgG4-related disease was diagnosed finally. The result 
indicated that IgG4-related disease could be a kind of 
benign lesions, and progress very slowly even without 
treatment.
Conclusions
IgG4-related disease is a systemic fibro-inflammatory 
immune-mediated disorder and now recognized in many 
organs. It is characterised with multiple enlarged lymph 
nodes and well response to glucocorticoids. IgG4-related 
disease progresses slowly,and in the present patient the 
course of IgG4-related disease appears to be benign. The 
prognosis of IgG4-related disease is perhaps good as long 
as early detection and treatment.
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